Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30.2M
-
Number of holders
-
170
-
Total 13F shares, excl. options
-
15.3M
-
Shares change
-
+635K
-
Total reported value, excl. options
-
$300M
-
Value change
-
+$11.5M
-
Put/Call ratio
-
0.03
-
Number of buys
-
87
-
Number of sells
-
-77
-
Price
-
$19.62
Significant Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q2 2024
213 filings reported holding FLGT - Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2024.
Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) has 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.3M shares
of 30.2M outstanding shares and own 50.56% of the company stock.
Largest 10 shareholders include BlackRock Inc. (3.92M shares), VANGUARD GROUP INC (1.44M shares), DIMENSIONAL FUND ADVISORS LP (1.22M shares), MILLENNIUM MANAGEMENT LLC (959K shares), Park West Asset Management LLC (833K shares), STATE STREET CORP (783K shares), Divisadero Street Capital Management, LP (505K shares), GEODE CAPITAL MANAGEMENT, LLC (490K shares), MORGAN STANLEY (369K shares), and AMERIPRISE FINANCIAL INC (355K shares).
This table shows the top 170 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.